ArticleNature communications2026
Functional alignment of protein language models via reinforcement learning.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Protein language models (pLMs) enable generative design of novel protein sequences but remain fundamentally misaligned with protein engineering goals, as they lack explicit understanding of function and often fail to improve properties beyond those found in nature. We introduce Reinforcement Learning from eXperimental Feedback (RLXF), a general framework that aligns protein language models with experimentally measured functional objectives, drawing inspiration from the methods used to align large language models like ChatGPT. Applied across five diverse protein families, RLXF improves generation of high-functioning variants beyond pre-trained baselines. We demonstrate this with CreiLOV, an oxygen-independent fluorescent protein, where RLXF-aligned models generate sequences with significantly enhanced fluorescence, including the most fluorescent CreiLOV variants reported to date. Our results indicate that RLXF-aligned models effectively integrate the evolutionary knowledge encoded in pre-trained pLMs with experimental observations, improving the success rate of generated sequences and enabling the discovery of synergistic mutation combinations that are difficult to identify through zero-shot or evolutionary approaches. RLXF provides a scalable and accessible approach to steer generative models toward desired biochemical properties, enabling function-driven protein design beyond the limits of natural evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.